Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

The coronary angiography devices market has witnessed significant expansion recently, driven by advancements in cardiac care and growing healthcare infrastructure worldwide. With an increasing focus on early diagnosis and treatment of heart diseases, this sector is set to experience continued growth in the coming years. Let’s explore the current market size, key growth drivers, segment breakdown, major players, and regional trends shaping this industry.

Steady Market Growth and Future Projections in Coronary Angiography Devices

The market for coronary angiography devices has shown robust growth and is projected to increase from $10.03 billion in 2025 to $10.7 billion in 2026, representing a compound annual growth rate (CAGR) of 6.7%. The expansion during this period is largely attributed to the rising prevalence of coronary artery disease, a higher frequency of cardiac catheterization procedures, the development of hospital cardiac care facilities, wider adoption of x-ray angiography systems, and an enhanced focus on early detection of heart conditions. Looking ahead, the market is expected to reach $13.83 billion by 2030, growing at a CAGR of 6.6%, fueled by factors such as an aging population at greater cardiovascular risk, increased demand for precise coronary diagnostics, expansion of interventional cardiology centers, adoption of image-guided procedures, and a growing emphasis on preventive cardiology. Key trends predicted for the forecast period include a shift toward minimally invasive diagnostic techniques, increased use of advanced imaging technology, heightened demand for accurate coronary visualization, broader application of angiography in early cardiac disease detection, and the integration of diagnostic and therapeutic workflows.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18800&type=smp

Rising Prevalence of Vascular Heart Diseases Boosting Market Demand

A significant driver behind the growth of the coronary angiography devices market is the increasing incidence of vascular heart diseases. These conditions affect the heart’s blood vessels and are influenced by lifestyle changes, such as poor diet and reduced physical activity, alongside an aging population and rising rates of diabetes and hypertension. Coronary angiography devices play a crucial role in diagnosing these diseases by producing detailed images of coronary arteries, helping healthcare providers pinpoint blockages and abnormalities to guide treatment strategies. For example, in October 2024, the US Centers for Disease Control and Prevention reported that cardiovascular disease caused 919,032 deaths in 2023, accounting for roughly one in every three fatalities. This high prevalence of vascular conditions continues to drive demand for coronary angiography devices.

Expanding Cardiac Care Infrastructure and Technological Adoption Fueling Market Growth

Another factor propelling market growth is the ongoing expansion of cardiac care infrastructure and the increasing use of advanced diagnostic technologies. Healthcare facilities worldwide are investing in state-of-the-art imaging systems and catheterization labs to enhance cardiac diagnostics and interventions. This infrastructure growth supports the rising volume of cardiac catheterization procedures and broadens access to high-quality coronary angiography, thereby increasing market demand.

Access The Complete Coronary Angiography Devices Market Report:

https://www.thebusinessresearchcompany.com/report/coronary-angiography-devices-global-market-report

In-Depth Segmentation of the Coronary Angiography Devices Market

This market is segmented comprehensively by product type, technology, indication, application, and end-user. Product categories include angiography systems, catheters, contrast media, vascular closure devices, balloons, guidewires, and accessories. Technology-wise, the market covers x-ray angiography, computed tomography angiography (CTA), magnetic resonance angiography, and other emerging technologies. Indications include coronary artery disease, valvular heart disease, congenital heart disease, congestive heart failure, and other cardiac conditions. The applications split between diagnostics and therapeutics, while end-users primarily consist of hospitals and clinics, diagnostic and imaging centers, and research institutes. Further subcategories detail specific system types such as 3D or 4D angiography systems and digital subtraction angiography; catheter types including diagnostic and therapeutic variants; contrast media types; vascular closure device categories; balloon types; guidewire classifications; and various supportive accessories.

Technological Innovations Shaping the Future of Coronary Angiography Devices

Key players in the coronary angiography devices market are focusing heavily on innovation, particularly the development of next-generation drug-eluting stents. These advanced stents feature improved scaffolding, drug coatings, and delivery mechanisms designed to reduce arterial restenosis and promote better healing of blood vessels. For example, in May 2024, Abbott Laboratories introduced its XIENCE Sierra stent in India, which offers enhanced flexibility, precise deployment, and improved safety. This launch aims to provide cardiologists with better treatment options and raise the standard of care for coronary artery disease, illustrating a broader industry commitment to combining cutting-edge design with clinical needs to improve patient outcomes.

Established Corporations Leading the Coronary Angiography Devices Market

The market features several prominent companies including Cardinal Health Inc., Johnson & Johnson Services Inc., Abbott Laboratories, Medtronic plc, Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Boston Scientific Corporation, B. Braun Holding GmbH & Co. KG, Terumo Corporation, Nipro Corporation, Shimadzu Corporation, Cook Group Incorporated, ICU Medical Inc., Biotronik SE Co. KG, Merit Medical Systems Inc., Cordis Corporation, Guerbet N.V., AngioDynamics Inc., Canon Medical Systems Corporation, Acist Medical Systems, Medinol Ltd., and Alvimedica. These firms are key contributors to technological advancement, market expansion, and increased access to coronary angiography solutions worldwide.

Regional Market Dynamics with North America Leading and Asia-Pacific Rising Fast

In 2025, North America held the largest share of the coronary angiography devices market. However, the Asia-Pacific region is anticipated to experience the fastest growth during the forecast period. The market report covers key geographic areas including Asia-Pacific, South East Asia, Western and Eastern Europe, North America, South America, the Middle East, and Africa, providing a global perspective on trends and opportunities.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model